Zacks Investment Research
26 May 2026, 17:45 UTC · 1h ago
Source · https://www.zacks.com/stock/news/2927044/o-reilly-automotive-orly-is-an-incredible-growth-stock-3-reasons-why?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_11_growth-2927044
Read source
Search tags
Story key points
3 claims · impact-rated
O'Reilly Automotive (ORLY) is projected to have EPS growth of 9.2% this year, significantly outperforming the industry average of 4%. — Stronger-than-peers earnings growth is a primary driver for individual stock price appreciation.
+0.40O'Reilly Automotive is reporting year-over-year cash flow growth of 6.1%. — Positive cash flow growth supports operational sustainability and internal funding for growth projects.
+0.20Zacks Equity Research currently assigns O'Reilly Automotive a top Zacks Rank and a favorable Growth Style Score. — Positive analyst ratings can increase buying interest but are secondary to the actual financial growth figures.
+0.10Impact vectors
1 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Ticker attribution
Model heads
Recommended as a cutting-edge growth stock with a top Zacks Rank and expected earnings growth that crushes the industry average.
Mentioned only as a highly viewed stock on the platform without any qualitative analysis.
Mentioned only as a highly viewed stock on the platform without any qualitative analysis.
Mentioned only as a stock with high page view growth.
Mentioned only as a stock with high page view growth.
Mentioned only as a stock with high page view growth.
Mentioned only as a highly viewed stock on the platform without any qualitative analysis.
Mentioned only as a stock with high page view growth.
Mentioned only as a highly viewed stock on the platform without any qualitative analysis.
Mentioned only as a stock with high page view growth.
Mentioned only as a highly viewed stock on the platform without any qualitative analysis.
Mentioned only as a highly viewed stock on the platform without any qualitative analysis.
No ticker relationship head found.
